As of April 30, 2025, Pfizer's stock price stands at $22.78, which is slightly higher than the day's low of $22.23 but lower than the day's high of $22.86. The trading volume on this day was 34,935,506 shares, which is significantly higher than the average trading volume for Pfizer.

Looking at the historical data, Pfizer's stock price has been relatively stable over the past few months. In February 2025, the stock price began at $34.45 and ended at $34.90, showing a 1.3 percent increase. In March 2025, the price started at $34.90 and ended at $34.94, with a minimal 0.1 percent change. As of April 2025, the stock price began at $34.94 and is expected to end at $35.40, indicating a 1.3 percent increase.

Recent news and announcements about Pfizer include its ongoing efforts to respond to the COVID-19 pandemic. The company has been at the forefront of vaccine development, particularly with the Pfizer-BioNTech COVID-19 vaccine. Additionally, Pfizer has been investing in its product pipeline, with several regulatory submissions and clinical trial results expected in the coming months.

Major analyst updates and price target changes have also been noted. According to recent forecasts, Pfizer's stock price is predicted to reach $24.58 by the end of April 2025, with a maximum of $26.55 and a minimum of $22.61. By July 2025, the forecasted price is expected to be around $30.49, with a maximum of $32.93 and a minimum of $28.05[5].

Overall, while Pfizer's stock price has shown stability, the company's ongoing efforts in vaccine development and its robust product pipeline suggest potential for future growth. The significant trading volume indicates investor interest, and the forecasts from analysts suggest a positive outlook for the stock in the coming months.

For more http://www.quietplease.ai

Stock up on these deals
https://amzn.to/3QFpYIX

This content was created in partnership and with the help of Artificial Intelligence AI